NCT03914001 is a NA clinical trial of mpMRI in Bladder Cancer, sponsored by Mansoura University.

Who is sponsoring NCT03914001?

NCT03914001 is sponsored by Mansoura University.

What drugs are being tested in NCT03914001?

Interventions in NCT03914001: mpMRI, Second look TURBT.

What condition does NCT03914001 study?

NCT03914001 studies Bladder Cancer.

Is NCT03914001 still recruiting?

NCT03914001 is currently status unknown. Last updated 12 April 2019.

Last reviewed 2019-04-12 · How we verify

NCT03914001

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comprehensive Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Non Muscle-invasive Bladder Tumor; Can it Replace Second Look Biopsy? A Prospective Study

Status unknown NA Last updated 12 April 2019

What this trial tests

NA trial testing mpMRI in Bladder Cancer in 100 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
1 April 2020

1 June 2020

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	100
Start date	1 April 2019
Primary completion	1 April 2020
Estimated completion	1 June 2020
Sites	1 location across Egypt

Drugs / interventions tested

mpMRI
Second look TURBT

Conditions studied

Bladder Cancer — all drugs for Bladder Cancer →

Sponsor

Mansoura University

Who can join

18 and older, any sex, with Bladder Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to prospectively assess the role of mpMRI as a non invasive method for assessment of possible residual tumor after initial resection of non muscle invasive bladder tumor.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications.
Séguier D, Puech P, Kool R, Dernis L, et al · · 2021 · cited 20× · PMID 34457041 · DOI 10.1177/17562872211039583

Verify or expand the search:

Other trials of mpMRI

Trials testing the same drug.

NCT06640153 — MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma · active not recruiting
NCT06407375 — Assessment of Renal Function by Multiparametric MRI · EARLY_PHASE1 · completed
NCT04692675 — Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Underg · NA · recruiting
NCT03960112 — Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cance · NA · unknown
NCT03730324 — Predicting Prostate Biopsy Results With Biomarkers and mpMRI. · NA · completed

Other recruiting trials for Bladder Cancer

Currently open trials in the same condition.

NCT07419295 — A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) · Phase 3 · recruiting
NCT07322263 — Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC · Phase 2 · recruiting
NCT07420517 — Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer · Phase 2 · recruiting
NCT07475403 — Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer · Phase 2 · recruiting
NCT07277413 — A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · Phase 1 · recruiting

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03914001 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 12 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03914001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing